VHVI
Nashville, Tennessee, 37232, United States
NCT Number: NCT04336995
The study seeks to measure pulmonary transit time via contrast-echocardiography before and after exercise.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Nashville, Tennessee, 37232, United States
The ability to measure the amount of blood in the lungs using heart-ultrasound (echocardiography) can be useful to estimate how much fluid is in a patient's circulation, which can influence diagnosis and treatment of certain types of heart failure. In some patients, the amount of fluid is normal at rest, but can increase with activity and thus a diagnosis of heart failure can only be made after exercising. Currently, the amount of fluid is measured invasively. We have shown that echocardiography can measure the amount of fluid in the lung circulation at rest without the need for an invasive procedure. We now seek to find out if we can make a similar measurement after exercise. If successful, the need for catheter procedures may be reduced in certain types of heart failure.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
giving echocardiographic contrast and taking echocardiographic images before and after exercise
Time frame: 3-10 seconds
interval required for the pulmonary blood volume to traverse the pulmonary circulation
Vanderbilt University Medical Center
Other
Echocardiographic Assessment of Pulmonary Transit Time Following Exercise
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05887271
Body Weight, Cardiovascular Diseases
Leicester, Leicestershire, United Kingdom
View Trial DetailsNCT04068844
Behavior, Cardiovascular Diseases
Dallas, Texas, United States
View Trial DetailsNCT05752760
Cardiovascular Diseases, Heart Diseases
Milwaukee, Wisconsin, United States
View Trial DetailsNCT05764564
Cardiovascular Diseases, Heart Diseases
Durham, North Carolina, United States
View Trial Details